The Impact of Preoperative Low Body Mass Index on Postoperative Complications and Long-term Survival Outcomes in Gastric Cancer Patients
The aim of this study was to investigate the impact of preoperative low body mass index (BMI) on both the short- and long-term outcomes in patients with gastric cancer. A total of 510 patients with gastric cancer were divided into the following 3 groups: low BMI group (≤18.5 kg/m , n=51), normal BMI...
Saved in:
| Published in | Journal of gastric cancer Vol. 18; no. 3; pp. 274 - 286 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Korea (South)
The Korean Gastric Cancer Association
01.09.2018
대한위암학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2093-582X 2093-5641 |
| DOI | 10.5230/jgc.2018.18.e30 |
Cover
| Abstract | The aim of this study was to investigate the impact of preoperative low body mass index (BMI) on both the short- and long-term outcomes in patients with gastric cancer.
A total of 510 patients with gastric cancer were divided into the following 3 groups: low BMI group (≤18.5 kg/m
, n=51), normal BMI group (18.6-24.9 kg/m
, n=308), and high BMI group (≥25.0 kg/m
, n=151).
There were significantly more stage III/IV patients in the low BMI group than in the other groups (P=0.001). Severe postoperative complications were more frequent (P=0.010) and the survival was worse (P<0.001) in the low BMI group. The subgroup analysis indicated that survival was worse in the low BMI group of the stage I/II subgroup (P=0.008). The severe postoperative complication rate was higher in the low BMI group of the stage III/IV subgroup (P=0.001), although the recurrence rate and survival did not differ in the stage III/IV subgroup among all the BMI groups. Low BMI was an independent poor prognostic factor in the stage I/II subgroup (disease-free survival: hazard ratio [HR], 13.521; 95% confidence interval [CI], 1.186-154.197; P=0.036 and overall survival: HR, 5.130; 95% CI, 1.644-16.010; P=0.005), whereas low BMI was an independent risk factor for severe postoperative complications in the stage III/IV subgroup (HR, 17.158; 95% CI, 1.383-212.940; P=0.027).
Preoperative low BMI in patients with gastric cancer adversely affects survival among those with stage I/II disease and increases the severe postoperative complication rate among those with stage III/IV disease. |
|---|---|
| AbstractList | The aim of this study was to investigate the impact of preoperative low body mass index (BMI) on both the short- and long-term outcomes in patients with gastric cancer.PURPOSEThe aim of this study was to investigate the impact of preoperative low body mass index (BMI) on both the short- and long-term outcomes in patients with gastric cancer.A total of 510 patients with gastric cancer were divided into the following 3 groups: low BMI group (≤18.5 kg/m2, n=51), normal BMI group (18.6-24.9 kg/m2, n=308), and high BMI group (≥25.0 kg/m2, n=151).MATERIALS AND METHODSA total of 510 patients with gastric cancer were divided into the following 3 groups: low BMI group (≤18.5 kg/m2, n=51), normal BMI group (18.6-24.9 kg/m2, n=308), and high BMI group (≥25.0 kg/m2, n=151).There were significantly more stage III/IV patients in the low BMI group than in the other groups (P=0.001). Severe postoperative complications were more frequent (P=0.010) and the survival was worse (P<0.001) in the low BMI group. The subgroup analysis indicated that survival was worse in the low BMI group of the stage I/II subgroup (P=0.008). The severe postoperative complication rate was higher in the low BMI group of the stage III/IV subgroup (P=0.001), although the recurrence rate and survival did not differ in the stage III/IV subgroup among all the BMI groups. Low BMI was an independent poor prognostic factor in the stage I/II subgroup (disease-free survival: hazard ratio [HR], 13.521; 95% confidence interval [CI], 1.186-154.197; P=0.036 and overall survival: HR, 5.130; 95% CI, 1.644-16.010; P=0.005), whereas low BMI was an independent risk factor for severe postoperative complications in the stage III/IV subgroup (HR, 17.158; 95% CI, 1.383-212.940; P=0.027).RESULTSThere were significantly more stage III/IV patients in the low BMI group than in the other groups (P=0.001). Severe postoperative complications were more frequent (P=0.010) and the survival was worse (P<0.001) in the low BMI group. The subgroup analysis indicated that survival was worse in the low BMI group of the stage I/II subgroup (P=0.008). The severe postoperative complication rate was higher in the low BMI group of the stage III/IV subgroup (P=0.001), although the recurrence rate and survival did not differ in the stage III/IV subgroup among all the BMI groups. Low BMI was an independent poor prognostic factor in the stage I/II subgroup (disease-free survival: hazard ratio [HR], 13.521; 95% confidence interval [CI], 1.186-154.197; P=0.036 and overall survival: HR, 5.130; 95% CI, 1.644-16.010; P=0.005), whereas low BMI was an independent risk factor for severe postoperative complications in the stage III/IV subgroup (HR, 17.158; 95% CI, 1.383-212.940; P=0.027).Preoperative low BMI in patients with gastric cancer adversely affects survival among those with stage I/II disease and increases the severe postoperative complication rate among those with stage III/IV disease.CONCLUSIONSPreoperative low BMI in patients with gastric cancer adversely affects survival among those with stage I/II disease and increases the severe postoperative complication rate among those with stage III/IV disease. Purpose: The aim of this study was to investigate the impact of preoperative low body mass index (BMI) on both the short- and long-term outcomes in patients with gastric cancer. Materials and Methods: A total of 510 patients with gastric cancer were divided into the following 3 groups: low BMI group (≤18.5 kg/m2, n=51), normal BMI group (18.6–24.9 kg/m2, n=308), and high BMI group (≥25.0 kg/m2, n=151). Results: There were significantly more stage III/IV patients in the low BMI group than in the other groups (P=0.001). Severe postoperative complications were more frequent (P=0.010) and the survival was worse (P<0.001) in the low BMI group. The subgroup analysis indicated that survival was worse in the low BMI group of the stage I/II subgroup (P=0.008). The severe postoperative complication rate was higher in the low BMI group of the stage III/IV subgroup (P=0.001), although the recurrence rate and survival did not differ in the stage III/IV subgroup among all the BMI groups. Low BMI was an independent poor prognostic factor in the stage I/II subgroup (disease-free survival: hazard ratio [HR], 13.521; 95% confidence interval [CI], 1.186–154.197; P=0.036 and overall survival: HR, 5.130; 95% CI, 1.644–16.010; P=0.005), whereas low BMI was an independent risk factor for severe postoperative complications in the stage III/IV subgroup (HR, 17.158; 95% CI, 1.383–212.940; P=0.027). Conclusions: Preoperative low BMI in patients with gastric cancer adversely affects survival among those with stage I/II disease and increases the severe postoperative complication rate among those with stage III/IV disease. KCI Citation Count: 0 The aim of this study was to investigate the impact of preoperative low body mass index (BMI) on both the short- and long-term outcomes in patients with gastric cancer. A total of 510 patients with gastric cancer were divided into the following 3 groups: low BMI group (≤18.5 kg/m , n=51), normal BMI group (18.6-24.9 kg/m , n=308), and high BMI group (≥25.0 kg/m , n=151). There were significantly more stage III/IV patients in the low BMI group than in the other groups (P=0.001). Severe postoperative complications were more frequent (P=0.010) and the survival was worse (P<0.001) in the low BMI group. The subgroup analysis indicated that survival was worse in the low BMI group of the stage I/II subgroup (P=0.008). The severe postoperative complication rate was higher in the low BMI group of the stage III/IV subgroup (P=0.001), although the recurrence rate and survival did not differ in the stage III/IV subgroup among all the BMI groups. Low BMI was an independent poor prognostic factor in the stage I/II subgroup (disease-free survival: hazard ratio [HR], 13.521; 95% confidence interval [CI], 1.186-154.197; P=0.036 and overall survival: HR, 5.130; 95% CI, 1.644-16.010; P=0.005), whereas low BMI was an independent risk factor for severe postoperative complications in the stage III/IV subgroup (HR, 17.158; 95% CI, 1.383-212.940; P=0.027). Preoperative low BMI in patients with gastric cancer adversely affects survival among those with stage I/II disease and increases the severe postoperative complication rate among those with stage III/IV disease. |
| Author | Kim, Jin-Jo Park, Seung-Man Kim, Chang Hyun |
| AuthorAffiliation | Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea |
| AuthorAffiliation_xml | – name: Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea |
| Author_xml | – sequence: 1 givenname: Chang Hyun orcidid: 0000-0003-1567-4318 surname: Kim fullname: Kim, Chang Hyun organization: Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea – sequence: 2 givenname: Seung-Man surname: Park fullname: Park, Seung-Man organization: Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea – sequence: 3 givenname: Jin-Jo orcidid: 0000-0003-1011-8793 surname: Kim fullname: Kim, Jin-Jo organization: Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30276004$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002392248$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNp1Uk1v1DAQtVARLaVnbshHOGTr2HG8uSCVFZSVFnUFi8TNcpzJ1m1iB9tZ6D_gZ-Nmu3xJWCPN2H7vzch-T9GRdRYQep6TGaeMnN9s9YySfD5LAYw8QieUVCzjZZEfHeo5_XKMzkK4IWnxMs8JfYKOGaGiJKQ4QT8214CX_aB0xK7Faw9uAK-i2QFeuW_4jWvu8AcVAl7aBr5jZ_HahfgbtHD90BmdNs4GrGyTaHabRfA9_jT6ndmpDl-NUbseAjYWX6oQvdF4oawGj9eJCTaGZ-hxq7oAZw_5FH1-93azeJ-tri6Xi4tVpgsqYgaigVqxtqmbOdEFL1gpuKLzgitdq7alnDTAaNswLoADF7ROh5WoGJQ1Kxg7Ra_2uta38lYb6ZSZ8tbJWy8vPm6WkomyYpwn7Os9dhjrHhqd5vSqk4M3vfJ3E_PvG2uuk85OlnlJOCNJ4OWDgHdfRwhR9iZo6DplwY1B0jzngvNqmuvFn71-NTl8VQLwPUB7F4KHVmoTp2dPrU0ncyLvXSGTK-S9K2QKmGY4_4d3kP4f4yc8A7ze |
| CitedBy_id | crossref_primary_10_1371_journal_pone_0317985 crossref_primary_10_3389_fonc_2022_899677 crossref_primary_10_7704_kjhugr_2023_0056 crossref_primary_10_1007_s10278_024_01172_0 crossref_primary_10_1002_ags3_12353 crossref_primary_10_5230_jgc_2019_19_e29 crossref_primary_10_1016_j_nupar_2024_06_002 crossref_primary_10_1016_j_esmoop_2024_102241 crossref_primary_10_1186_s12885_024_12349_9 crossref_primary_10_4162_nrp_2022_16_5_604 |
| Cites_doi | 10.1186/s12957-016-1076-1 10.1097/01.sla.0000133083.54934.ae 10.1016/j.jamcollsurg.2015.01.058 10.1007/s10120-015-0531-y 10.5230/jgc.2011.11.1.1 10.1016/j.jss.2016.01.005 10.1186/s12957-015-0713-4 10.1007/PL00011708 10.1007/s10120-011-0040-6 10.1007/s11605-010-1201-3 10.1097/SLA.0b013e31823dcbf7 10.1007/s00595-010-4397-7 10.1002/bjs.9380 10.5230/jgc.2011.11.2.69 10.1097/MD.0000000000003781 10.1093/icvts/ivw175 10.1016/j.ejca.2015.10.061 10.1016/j.ctrv.2015.10.003 10.4143/crt.2015.060 10.1097/SLE.0b013e318219a57d 10.1245/s10434-010-1362-z 10.1016/j.jss.2010.03.012 10.1016/S0140-6736(03)15268-3 10.1016/j.ejso.2017.01.004 10.1016/j.jss.2014.12.048 10.1097/IGC.0b013e31822d2aa3 10.1159/000440654 10.1007/s00404-011-2116-2 10.1007/s11605-013-2238-x 10.1200/JCO.2015.61.6441 10.1245/s10434-014-3664-z 10.1002/jso.10050 10.1016/j.gassur.2004.09.033 10.3748/wjg.v12.i3.354 10.1371/journal.pone.0157401 10.1007/s00432-014-1714-3 10.1007/s10120-012-0163-4 10.1016/S1470-2045(15)00475-1 |
| ContentType | Journal Article |
| Copyright | Copyright © 2018. Korean Gastric Cancer Association 2018 Korean Gastric Cancer Association |
| Copyright_xml | – notice: Copyright © 2018. Korean Gastric Cancer Association 2018 Korean Gastric Cancer Association |
| DBID | AAYXX CITATION NPM 7X8 5PM ACYCR |
| DOI | 10.5230/jgc.2018.18.e30 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2093-5641 |
| EndPage | 286 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_3769355 PMC6160530 30276004 10_5230_jgc_2018_18_e30 |
| Genre | Journal Article |
| GroupedDBID | 5-W 53G 8JR 8XY 9ZL AAYXX ABDBF ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS CITATION EF. HYE KQ8 KVFHK M48 OK1 PGMZT RPM NPM 7X8 5PM ACYCR M~E |
| ID | FETCH-LOGICAL-c427t-e7deba3fdbd80c4543675a2845acbaff250de32fd357e5e572bff29793e6b3433 |
| IEDL.DBID | M48 |
| ISSN | 2093-582X |
| IngestDate | Tue Nov 21 21:40:08 EST 2023 Thu Aug 21 17:43:29 EDT 2025 Thu Jul 10 23:45:44 EDT 2025 Thu Apr 03 07:05:30 EDT 2025 Tue Jul 01 02:55:11 EDT 2025 Thu Apr 24 23:12:30 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Body mass index Obesity Stomach neoplasms Underweight |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c427t-e7deba3fdbd80c4543675a2845acbaff250de32fd357e5e572bff29793e6b3433 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0003-1567-4318 0000-0003-1011-8793 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.5230/jgc.2018.18.e30 |
| PMID | 30276004 |
| PQID | 2115755943 |
| PQPubID | 23479 |
| PageCount | 13 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_3769355 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6160530 proquest_miscellaneous_2115755943 pubmed_primary_30276004 crossref_citationtrail_10_5230_jgc_2018_18_e30 crossref_primary_10_5230_jgc_2018_18_e30 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-09-01 |
| PublicationDateYYYYMMDD | 2018-09-01 |
| PublicationDate_xml | – month: 09 year: 2018 text: 2018-09-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Korea (South) |
| PublicationPlace_xml | – name: Korea (South) |
| PublicationTitle | Journal of gastric cancer |
| PublicationTitleAlternate | J Gastric Cancer |
| PublicationYear | 2018 |
| Publisher | The Korean Gastric Cancer Association 대한위암학회 |
| Publisher_xml | – name: The Korean Gastric Cancer Association – name: 대한위암학회 |
| References | Dindo (10.5230/jgc.2018.18.e30_ref34) 2004; 240 Kodera (10.5230/jgc.2018.18.e30_ref20) 2004; 51 Migita (10.5230/jgc.2018.18.e30_ref36) 2016; 19 Lieberman (10.5230/jgc.2018.18.e30_ref39) 1990; 108 Renfro (10.5230/jgc.2018.18.e30_ref26) 2016; 34 Sun (10.5230/jgc.2018.18.e30_ref38) 2014; 140 Kanda (10.5230/jgc.2018.18.e30_ref12) 2016; 95 Inagawa (10.5230/jgc.2018.18.e30_ref21) 2000; 3 Jeong (10.5230/jgc.2018.18.e30_ref5) 2011; 11 Nobuoka (10.5230/jgc.2018.18.e30_ref19) 2011; 41 WHO Expert Consultation (10.5230/jgc.2018.18.e30_ref33) 2004; 363 Shibakita (10.5230/jgc.2018.18.e30_ref27) 2010; 57 Jung (10.5230/jgc.2018.18.e30_ref3) 2015; 47 Tsai (10.5230/jgc.2018.18.e30_ref18) 2010; 14 Wada (10.5230/jgc.2018.18.e30_ref35) 2015; 32 Ejaz (10.5230/jgc.2018.18.e30_ref10) 2015; 195 Hsu (10.5230/jgc.2018.18.e30_ref11) 2016; 202 Balentine (10.5230/jgc.2018.18.e30_ref16) 2010; 163 Makino (10.5230/jgc.2018.18.e30_ref15) 2012; 255 Lee (10.5230/jgc.2018.18.e30_ref24) 2016; 52 Kim (10.5230/jgc.2018.18.e30_ref4) 2002; 79 Santoso (10.5230/jgc.2018.18.e30_ref14) 2012; 285 Norero (10.5230/jgc.2018.18.e30_ref41) 2017; 43 Nashimoto (10.5230/jgc.2018.18.e30_ref6) 2013; 16 An (10.5230/jgc.2018.18.e30_ref2) 2011; 11 Chen (10.5230/jgc.2018.18.e30_ref23) 2017; 15 Balakrishnan (10.5230/jgc.2018.18.e30_ref25) 2015; 16 Liu (10.5230/jgc.2018.18.e30_ref9) 2016; 11 Kim (10.5230/jgc.2018.18.e30_ref22) 2011; 21 Washington (10.5230/jgc.2018.18.e30_ref31) 2010; 17 Backes (10.5230/jgc.2018.18.e30_ref17) 2011; 21 Ruffmann (10.5230/jgc.2018.18.e30_ref40) 1987; 1 Nishijima (10.5230/jgc.2018.18.e30_ref13) 2015; 41 Papenfuss (10.5230/jgc.2018.18.e30_ref43) 2014; 21 Nakagawa (10.5230/jgc.2018.18.e30_ref28) 2016; 23 Lien (10.5230/jgc.2018.18.e30_ref37) 2004; 8 Li (10.5230/jgc.2018.18.e30_ref29) 2015; 13 Selby (10.5230/jgc.2018.18.e30_ref42) 2015; 220 Crew (10.5230/jgc.2018.18.e30_ref1) 2006; 12 Lin (10.5230/jgc.2018.18.e30_ref8) 2013; 17 Li (10.5230/jgc.2018.18.e30_ref30) 2015; 12 van de Velde (10.5230/jgc.2018.18.e30_ref7) 2014; 101 Sano (10.5230/jgc.2018.18.e30_ref32) 2011; 14 |
| References_xml | – volume: 15 start-page: 52 year: 2017 ident: 10.5230/jgc.2018.18.e30_ref23 publication-title: World J Surg Oncol doi: 10.1186/s12957-016-1076-1 – volume: 240 start-page: 205 year: 2004 ident: 10.5230/jgc.2018.18.e30_ref34 publication-title: Ann Surg doi: 10.1097/01.sla.0000133083.54934.ae – volume: 220 start-page: 863 year: 2015 ident: 10.5230/jgc.2018.18.e30_ref42 publication-title: J Am Coll Surg doi: 10.1016/j.jamcollsurg.2015.01.058 – volume: 19 start-page: 735 year: 2016 ident: 10.5230/jgc.2018.18.e30_ref36 publication-title: Gastric Cancer doi: 10.1007/s10120-015-0531-y – volume: 11 start-page: 1 year: 2011 ident: 10.5230/jgc.2018.18.e30_ref2 publication-title: J Gastric Cancer doi: 10.5230/jgc.2011.11.1.1 – volume: 108 start-page: 452 year: 1990 ident: 10.5230/jgc.2018.18.e30_ref39 publication-title: Surgery – volume: 202 start-page: 284 year: 2016 ident: 10.5230/jgc.2018.18.e30_ref11 publication-title: J Surg Res doi: 10.1016/j.jss.2016.01.005 – volume: 13 start-page: 294 year: 2015 ident: 10.5230/jgc.2018.18.e30_ref29 publication-title: World J Surg Oncol doi: 10.1186/s12957-015-0713-4 – volume: 3 start-page: 141 year: 2000 ident: 10.5230/jgc.2018.18.e30_ref21 publication-title: Gastric Cancer doi: 10.1007/PL00011708 – volume: 14 start-page: 97 year: 2011 ident: 10.5230/jgc.2018.18.e30_ref32 publication-title: Gastric Cancer doi: 10.1007/s10120-011-0040-6 – volume: 14 start-page: 1143 year: 2010 ident: 10.5230/jgc.2018.18.e30_ref18 publication-title: J Gastrointest Surg doi: 10.1007/s11605-010-1201-3 – volume: 255 start-page: 228 year: 2012 ident: 10.5230/jgc.2018.18.e30_ref15 publication-title: Ann Surg doi: 10.1097/SLA.0b013e31823dcbf7 – volume: 41 start-page: 928 year: 2011 ident: 10.5230/jgc.2018.18.e30_ref19 publication-title: Surg Today doi: 10.1007/s00595-010-4397-7 – volume: 51 start-page: 1225 year: 2004 ident: 10.5230/jgc.2018.18.e30_ref20 publication-title: Hepatogastroenterology – volume: 101 start-page: 31 year: 2014 ident: 10.5230/jgc.2018.18.e30_ref7 publication-title: Br J Surg doi: 10.1002/bjs.9380 – volume: 57 start-page: 62 year: 2010 ident: 10.5230/jgc.2018.18.e30_ref27 publication-title: Hepatogastroenterology – volume: 11 start-page: 69 year: 2011 ident: 10.5230/jgc.2018.18.e30_ref5 publication-title: J Gastric Cancer doi: 10.5230/jgc.2011.11.2.69 – volume: 95 start-page: e3781 year: 2016 ident: 10.5230/jgc.2018.18.e30_ref12 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000003781 – volume: 23 start-page: 560 year: 2016 ident: 10.5230/jgc.2018.18.e30_ref28 publication-title: Interact Cardiovasc Thorac Surg doi: 10.1093/icvts/ivw175 – volume: 52 start-page: 129 year: 2016 ident: 10.5230/jgc.2018.18.e30_ref24 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2015.10.061 – volume: 41 start-page: 971 year: 2015 ident: 10.5230/jgc.2018.18.e30_ref13 publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2015.10.003 – volume: 47 start-page: 127 year: 2015 ident: 10.5230/jgc.2018.18.e30_ref3 publication-title: Cancer Res Treat doi: 10.4143/crt.2015.060 – volume: 21 start-page: 151 year: 2011 ident: 10.5230/jgc.2018.18.e30_ref22 publication-title: Surg Laparosc Endosc Percutan Tech doi: 10.1097/SLE.0b013e318219a57d – volume: 17 start-page: 3077 year: 2010 ident: 10.5230/jgc.2018.18.e30_ref31 publication-title: Ann Surg Oncol doi: 10.1245/s10434-010-1362-z – volume: 163 start-page: 35 year: 2010 ident: 10.5230/jgc.2018.18.e30_ref16 publication-title: J Surg Res doi: 10.1016/j.jss.2010.03.012 – volume: 363 start-page: 157 year: 2004 ident: 10.5230/jgc.2018.18.e30_ref33 publication-title: Lancet doi: 10.1016/S0140-6736(03)15268-3 – volume: 43 start-page: 1330 year: 2017 ident: 10.5230/jgc.2018.18.e30_ref41 publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2017.01.004 – volume: 195 start-page: 74 year: 2015 ident: 10.5230/jgc.2018.18.e30_ref10 publication-title: J Surg Res doi: 10.1016/j.jss.2014.12.048 – volume: 21 start-page: 1601 year: 2011 ident: 10.5230/jgc.2018.18.e30_ref17 publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0b013e31822d2aa3 – volume: 32 start-page: 480 year: 2015 ident: 10.5230/jgc.2018.18.e30_ref35 publication-title: Dig Surg doi: 10.1159/000440654 – volume: 285 start-page: 1139 year: 2012 ident: 10.5230/jgc.2018.18.e30_ref14 publication-title: Arch Gynecol Obstet doi: 10.1007/s00404-011-2116-2 – volume: 17 start-page: 1382 year: 2013 ident: 10.5230/jgc.2018.18.e30_ref8 publication-title: J Gastrointest Surg doi: 10.1007/s11605-013-2238-x – volume: 34 start-page: 144 year: 2016 ident: 10.5230/jgc.2018.18.e30_ref26 publication-title: J Clin Oncol doi: 10.1200/JCO.2015.61.6441 – volume: 21 start-page: 3008 year: 2014 ident: 10.5230/jgc.2018.18.e30_ref43 publication-title: Ann Surg Oncol doi: 10.1245/s10434-014-3664-z – volume: 1 start-page: 15 year: 1987 ident: 10.5230/jgc.2018.18.e30_ref40 publication-title: Cancer Detect Prev Suppl – volume: 79 start-page: 79 year: 2002 ident: 10.5230/jgc.2018.18.e30_ref4 publication-title: J Surg Oncol doi: 10.1002/jso.10050 – volume: 12 start-page: 394 year: 2015 ident: 10.5230/jgc.2018.18.e30_ref30 publication-title: Cancer Biol Med – volume: 8 start-page: 1041 year: 2004 ident: 10.5230/jgc.2018.18.e30_ref37 publication-title: J Gastrointest Surg doi: 10.1016/j.gassur.2004.09.033 – volume: 12 start-page: 354 year: 2006 ident: 10.5230/jgc.2018.18.e30_ref1 publication-title: World J Gastroenterol doi: 10.3748/wjg.v12.i3.354 – volume: 11 start-page: e0157401 year: 2016 ident: 10.5230/jgc.2018.18.e30_ref9 publication-title: PLoS One doi: 10.1371/journal.pone.0157401 – volume: 140 start-page: 1537 year: 2014 ident: 10.5230/jgc.2018.18.e30_ref38 publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-014-1714-3 – volume: 16 start-page: 1 year: 2013 ident: 10.5230/jgc.2018.18.e30_ref6 publication-title: Gastric Cancer doi: 10.1007/s10120-012-0163-4 – volume: 16 start-page: e593 year: 2015 ident: 10.5230/jgc.2018.18.e30_ref25 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(15)00475-1 |
| SSID | ssj0000561102 |
| Score | 2.1716013 |
| Snippet | The aim of this study was to investigate the impact of preoperative low body mass index (BMI) on both the short- and long-term outcomes in patients with... Purpose: The aim of this study was to investigate the impact of preoperative low body mass index (BMI) on both the short- and long-term outcomes in patients... |
| SourceID | nrf pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 274 |
| SubjectTerms | Original 일반외과학 |
| Title | The Impact of Preoperative Low Body Mass Index on Postoperative Complications and Long-term Survival Outcomes in Gastric Cancer Patients |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30276004 https://www.proquest.com/docview/2115755943 https://pubmed.ncbi.nlm.nih.gov/PMC6160530 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002392248 |
| Volume | 18 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Journal of Gastric Cancer, 2018, 18(3), , pp.274-286 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELZgkRAXxHvDY2UQBy4paWzncUJQsWwRhZWgUm-WHY9L2ZUDaSvYf8DPZibJdreoSEiWIiV2LHvG9nwe-xvGng9zgMxDibBElbE0No-tkUXsM-98VVrUMrooPPmYHU3l-5maXYQD6jtwuRPaUTypaXM6-PXj7BUOeLRfB7Sn-fLbnLgIh8UAEwjE79daZxGd4-tt_Y7oO8OljrwKKaL4WBXprKP62fWPrVXqamj8LgP073OUlxamw1vsZm9R8tedCtxmVyDcYdcnvc_8LvuNmsDH7WVIXnt-3AC2sOP75h_qn_xN7c74BG1oPibmRF4HThF8LzKNLp865yY4LBbmMc3p_PMapxpUVv5pvULdhSVfBP7OUDCQio9Ioxp-3FG3Lu-x6eHbL6OjuI-_EFcyzVcx5A6sEd5ZVySVVFIgujC4nilTWeM9Wk8OROqdUDkoUHlq8WWJIx4yK6QQ99leqAPsM455oJKFd0lmpDeJyZMcRKGcLcFX3kVscN7fuurJySlGxqlGkEIC0iggTQLSmFBAEXuxKfC94-X4d9ZnKEB9Ui00cWnTc17rk0YjYhhrQcEglYrY03P5ahxg5DUxAer1UqdER4S4S4qIPejkvamRnL5oMcqI5VuasMlAFW5_CYuvLYl3NkQgKZKH_1HvI3aDmtOdbHvM9lbNGp6gKbSyB62KH7R7VH8AZJcL-A |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Impact+of+Preoperative+Low+Body+Mass+Index+on+Postoperative+Complications+and+Long-term+Survival+Outcomes+in+Gastric+Cancer+Patients&rft.jtitle=Journal+of+gastric+cancer&rft.au=Kim%2C+Chang+Hyun&rft.au=Park%2C+Seung-Man&rft.au=Kim%2C+Jin-Jo&rft.date=2018-09-01&rft.issn=2093-582X&rft.volume=18&rft.issue=3&rft.spage=274&rft_id=info:doi/10.5230%2Fjgc.2018.18.e30&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-582X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-582X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-582X&client=summon |